Steering Committee Membership Sample Clauses

Steering Committee Membership. For each Procurement intended to be issued by Metrolinx pursuant to Section 3.5 (Decisions of a Steering Committee), there shall be a Steering Committee comprised of one representative from each of Metrolinx (the “Metrolinx Member”), GO Transit (provided that GO Transit is participating as a Purchaser in the particular Procurement), and one representative from each other Purchaser that intends to participate in that Procurement and has acknowledged the Terms of Reference as described in Section 2.1(d). For each Steering Committee, Metrolinx, GO Transit (as applicable), and each Purchaser may also appoint one Alternate Member, who can act on the Member’s behalf in the Member’s absence at Steering Committee meetings.
AutoNDA by SimpleDocs
Steering Committee Membership. The voting members of the Steering Committee shall consist of no fewer than six (6) and no more than twelve (12) persons divided into the following categories: (i) approximately one-third of the voting members of the Steering Committee shall be representatives of Company Members that are actively engaging in development of therapies for the treatment of TSC or planning to undertake such development efforts in the future (the “Company SC Members”); (ii) approximately one-third of the voting members shall be Academic Members (the “Academic SC Members”) and (iii) the remaining approximate one-third shall be representatives of the Foundation, TSC patient community or other patient organizations. The Consortium Director, who shall be solely designated by the Foundation, will be a voting member of the Steering Committee and shall serve without term limitation.
Steering Committee Membership. The Steering Committee will consist of approximately fifteen members. Two will he members of the Strategy Council, two will be appointed by the Union and the rest be selected from among volunteers to be representative of all groups in the RESOURCES Each member of the Steering Committee will be given eight hours of protected time each to carry out their mandate. Managers Group Leaders will work with the members to ensure the impact on day-today operations is while allowing the important work of the Steering Committee to be done in a timely manner. In-house meeting rooms will be provided for the Steering Committee on a priority basis. Training, facilitation the required information will be provided to the Committee to allow it to carry out its Mandate. An expense budget of a maximum of will be provided to the Steering Committee to be at its PROCESS TO BE USED TO DESIGN IMPLEMENT WORK TEAMS the this the Steering Committee will use the following process for design and of Work Teams in the manufacturing operations of • Create and champion the vision for Work Teams at • Create a Steering charter. • Develop a for the project. • Conduct technical analysis of work processes. • Conduct social analysis of work. • technical and social analysis. • Create design and implementation plan for Work Teams. • Implement approved • out ongoing of Work Team implementation. BOUNDARIES FOR STEERING COMMITTEE The Steering Committee will make decisions in the following areas: Design “Future Search” conference (if needed). steering committee Steering Committee development, and external resources as needed. Map work process flow. Determine appropriate appropriate management for Work Teams. Create a structure to support change to Work Teams. layout required Clarify role Create charter Work Teams and train members. set performance indicators. Work Continue maintenance of visible Senior Management. information needs of If requited, issues which impact on Collective Agreement and need resolution outside of committee. identify and determine required changes in job design. Change to team budgeting and accounting processes.
Steering Committee Membership. For each Transit Bus RFP intended to be issued by Metrolinx pursuant to section 6 (a) (Decisions of a Steering Committee), there shall be a Steering Committee comprised of one representative from Metrolinx and each Purchaser under the relevant RFP. For each Transit Bus Steering Committee, Metrolinx and each Purchaser may also appoint one Alternate Member, who can act on the Member’s behalf in their absence at Steering Committee meetings.
Steering Committee Membership. For each Public Tender intended to be issued by Metrolinx pursuant to Section 3.5 (Decisions of a Steering Committee), there shall be a Steering Committee comprising one representative from each of Metrolinx (the “Metrolinx Member”), GO Transit (provided that GO Transit is participating as a Purchaser in the particular Public Tender), and one representative from each other Purchaser participating in that Public Tender. For each Steering Committee, Metrolinx, GO Transit (as applicable), and each Purchaser may also appoint one Alternate Member, who can act on the Member’s behalf in the Member’s absence at Steering Committee meetings.
Steering Committee Membership. For each RFP intended to be issued by Metrolinx pursuant to Section 6(a) (Decisions of a Steering Committee), there shall be a Steering Committee comprising one representative from each of Metrolinx (the “Metrolinx Member”), GO Transit (to the extent that GO Transit is participating in that RFP), and one representative from each Purchaser under that RFP. For each Steering Committee, Metrolinx, GO Transit (as applicable), and each Purchaser may also appoint one Alternate Member, who can act on the Member’s behalf in the Member’s absence at Steering Committee meetings.
Steering Committee Membership. The following parties agree to participate collaboratively in the Steering Committee by appointing a Director or designee empowered to make decisions on behalf of the agency:
AutoNDA by SimpleDocs
Steering Committee Membership. The Steering Committee includes municipalities, state agencies, regional organizations, non-profit organizations, academic institutions, business interests, and other partners committed to building a livable, sustainable, and equitable region. It is the intent of the Steering Committee to conduct a process that is as inclusive as possible. Special efforts will be made to include and engage previously marginalized or under-represented constituencies. The Steering Committee membership as of March 8, 2011 is attached (Attachment A). These members were approved to participate by their municipality, agency, or organization and those entities may remove or replace their approved representative at any time. If an organization, agency or individual desires to become a member of the Steering Committee after May 15th, they or a current member shall submit a written request for consideration by the Steering Committee including a description of the added value they will contribute to the process. A vote of the Steering Committee is needed to approve a new member.
Steering Committee Membership. The Steering Committee will consist of each Party’s Account Manager and at least two (2) other representatives of each Party (but not more than six (6) as determined by Customer from time to time) as provided in the Account Governance Exhibit. The chairperson of the Steering Committee will be designated by Customer. The operating procedures for the Steering Committee are set forth in the Account Governance Exhibit and may be modified by the Parties from time to time during the Term upon mutual agreement.

Related to Steering Committee Membership

  • Committee Membership 1. Local representatives on committees specifically established by this Collective Agreement shall be appointed by the local.

  • Committee Members See Section 3.5(a). -----------------

  • Development Committee As soon as practicable, the Parties will establish a joint development committee, comprised of at least one (1) and up to two (2) representatives of Omega and at least one (1) and up to two (2) representatives of Acuitas (the “JDC”). One such representative from each Party will be such Party’s Workplan Leader. Each Party may replace its Workplan Leader and other JDC representatives at any time upon written notice to the other Party, provided, however, that each Party shall use reasonable efforts to ensure continuity on the JDC. With the consent of the other Party (which will not be unreasonably withheld, conditioned or delayed), each Party may invite non-voting employees and consultants to attend JDC meetings as necessary, subject to consultant’s agreement to be bound to the same extent as a permitted subcontractor under Section 3.1(i).

  • Steering Committee The Project Manager shall set up a Steering Committee for the Project, consisting of representatives from the Department, the Contractor, and any other key organisations whom the project will impact on, to be agreed between the parties. The function of the Steering Committee shall be to review the scope and direction of the Project against its aims and objectives, monitor progress and efficiency, and assess, manage and review expected impact and use of the findings from the Project. The Committee shall meet at times and dates agreed by the parties, or in the absence of agreement, specified by the Department. The Contractor’s representatives on the Steering Committee shall report their views on the progress of the Project to the Steering Committee in writing if requested by the Department. The Contractor’s representatives on the Steering Committee shall attend all meetings of the Steering Committee unless otherwise agreed by the Department.

  • Joint Steering Committee [***] following the Effective Date [***], a joint steering committee (the “JSC”) will be established by the Parties to provide oversight and to facilitate information sharing between the Parties with respect to the activities under this Agreement.

  • Joint Development Committee The Parties shall form a joint development committee (the “Joint Development Committee” or “JDC”), made up of an equal number of representatives of Merck and BioLineRx, which shall have responsibility of coordinating all regulatory and other activities under, and pursuant to, this Agreement. Each Party shall designate a project manager (the “Project Manager”) who shall be responsible for implementing and coordinating activities, and facilitating the exchange of information between the Parties, with respect to the Study. Other JDC members will be agreed by both Parties. The JDC shall meet as soon as practicable after the Effective Date and then no less than twice yearly, and more often as reasonably considered necessary at the request of either Party, to provide an update on the progress of the Study. The JDC may meet in person or by means of teleconference, Internet conference, videoconference or other similar communications equipment. Prior to any such meeting, the BioLineRx Project Manager shall provide an update in writing to the Merck Project Manager, which update shall contain information about the overall progress of the Study, recruitment status, interim analysis (if results available), final analysis and other information relevant to the conduct of the Study. In addition to a Project Manager, each Party shall designate an alliance manager (the “Alliance Manager”), who shall endeavor to ensure clear and responsive communication between the Parties and the effective exchange of information, and shall serve as the primary point of contact for any issues arising under this Agreement. The Alliance Managers shall have the right to attend all JDC meetings and may bring to the attention of the JDC any matters or issues either of them reasonably believes should be discussed, and shall have such other responsibilities as the Parties may mutually agree in writing. In the event that an issue arises and the Alliance Managers cannot or do not, after good faith efforts, reach agreement on such issue, the issue shall be elevated to the Head of Clinical Oncology for Merck and the Vice President of Medical Affairs or Business Development for BioLineRx.

  • Operating Committee the Consortium’s managing body, composed of representatives of the Manager and the Contractors, pursuant to Annex XI.

  • Joint Research Committee The Parties hereby establish a committee to facilitate the Research Program as follows:

  • Committee Meetings Subject to Article 19.3(1) and unless the directors otherwise provide in the resolution appointing the committee or in any subsequent resolution, with respect to a committee appointed under Articles 19.1 or 19.2:

  • Joint Project Team As soon as possible after the Effective Date, the Parties shall establish a joint project team (the “JPT”) which shall be initially responsible for the day-to-day operations of the Initial Target Program. The JPT shall also be responsible for the day-to-day operations of all other Collaboration Programs when they become ***Portions of this page have been omitted pursuant to a request for Confidential Treatment and filed separately with the Commission. effective; provided, that if multiple JPTs are needed due to different Targets or disease areas, then the Parties may establish separate JPTs for different Collaboration Programs. The JPT shall be comprised of representatives from each of GSK and Adaptimmune with the appropriate scientific expertise with respect to the conduct of the Development Plans (and such representatives may vary depending on the relevant Project Phase) and shall meet on a monthly basis (or more or less frequently as agreed by the Parties) at Adaptimmune’s facilities, GSK’s facilities or via teleconference at such times as may be agreed by the Parties during the term of the applicable Collaboration Program. The JPT will report to the JSC and will be responsible for the day-to-day management of the conduct of the Development Plans including any non-material changes to the Development Plans, overseeing the conduct of experiments and reviewing data resulting from such experiments as set forth in the Development Plans, proposing amendments to the Development Plans, proposing new Development Plans to the JSC for new Collaboration Programs for JSC approval, discussing potential Lead Candidates and Development Candidates for proposal to the JSC. All decisions of the JPT on matters for which it has responsibility shall be made unanimously. In the event that the JPT is unable to reach a unanimous decision within ten (10) Business Days after it has met and attempted to reach such decision, then either Party may, by written notice to the other, have such issue submitted to the JSC for resolution in accordance with Section 4.5. Each Party will bear all expenses it incurs in regard to participating in all meetings of the JPT, including all travel and living expenses. Each JPT shall automatically cease to exist on completion of the relevant Collaboration Programs that it supports and exercise or expiry of all Collaboration Program Options applicable to such Collaboration Programs.

Time is Money Join Law Insider Premium to draft better contracts faster.